{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:03:56Z","timestamp":1759777436722,"version":"3.40.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.urology.2015.11.042","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T02:16:17Z","timestamp":1452132977000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Prostate-specific Antigen Mass Density\u2014A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5731-1748","authenticated-orcid":false,"given":"Oleksandr N.","family":"Kryvenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireya","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Kates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory P.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2015.11.042_bib0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA Guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0015","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Banez","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2015.11.042_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1040-8428(03)00094-5","article-title":"Relationship between prostatic specific antigen (PSA) and volume of the prostate in the benign prostatic hyperplasia in the elderly","volume":"47","author":"Bo","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urology.2015.11.042_bib0025","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.urology.2013.12.054","article-title":"Biopsy criteria for determining appropriateness for active surveillance in the modern era","volume":"83","author":"Kryvenko","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.11.042_bib0030","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/modpathol.2012.51","article-title":"Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer","volume":"25","author":"Kryvenko","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urology.2015.11.042_bib0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pros.22928","article-title":"Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens","volume":"75","author":"Swanson","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2015.11.042_bib0040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2015.11.042_bib0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","article-title":"NCCN clinical practice guidelines in oncology: prostate cancer","volume":"8","author":"Mohler","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urology.2015.11.042_bib0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2013.06.021","article-title":"Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men","volume":"191","author":"Sundi","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1309\/AJCPQL9MKQ6VDDWL","article-title":"Correlation of high body mass index with more advanced localized prostate cancer at radical prostatectomy is not reflected in PSA level and PSA density but is seen in PSA mass","volume":"144","author":"Kryvenko","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urology.2015.11.042_bib0060","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1464-410X.2008.07883.x","article-title":"Variance inflation in sequential calculations of body surface area, plasma volume, and prostate-specific antigen mass","volume":"102","author":"Sivanandam","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2015.11.042_bib0065","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason score","author":"Epstein","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0070","doi-asserted-by":"crossref","DOI":"10.5858\/arpa.2015-0487-SA","article-title":"Prostate cancer grading: a decade after the 2005 Modified Gleason Grading System","author":"Kryvenko","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urology.2015.11.042_bib0075","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0022-5347(17)35302-8","article-title":"Prostate specific antigen and Gleason grade: an immunohistochemical study of prostate cancer","volume":"151","author":"Aihara","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0080","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/PAS.0b013e3182206da8","article-title":"Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy","volume":"35","author":"Al-Hussain","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2015.11.042_bib0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/modpathol.2010.178","article-title":"International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 1: specimen handling","volume":"24","author":"Samaratunga","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urology.2015.11.042_bib0090","doi-asserted-by":"crossref","DOI":"10.1177\/1066896915600519","article-title":"Average weight of seminal vesicles\u2014an adjustment factor for radical prostatectomy specimens weighed with seminal vesicles","author":"Tjionas","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.urology.2015.11.042_bib0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.juro.2010.03.138","article-title":"Prostate specific antigen mass ratio potential as a prostate cancer screening tool","volume":"184","author":"Choi","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0100","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1111\/j.1464-410X.2011.10764.x","article-title":"Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of <\/=10\u2009ng\/mL","volume":"110","author":"Hong","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2015.11.042_bib0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1590\/S1677-5538.IBJU.2014.04.06","article-title":"Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy","volume":"40","author":"Lee","year":"2014","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1055-9965.EPI-12-0965","article-title":"Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate","volume":"22","author":"Rundle","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2015.11.042_bib0115","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.ejca.2010.07.052","article-title":"Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe","volume":"46","author":"Renehan","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2015.11.042_bib0120","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/ijc.29238","article-title":"Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark","volume":"136","author":"Moller","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2015.11.042_bib0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ejso.2011.09.036","article-title":"The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis","volume":"37","author":"De Nunzio","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.urology.2015.11.042_bib0130","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.5858\/arpa.2014-0219-SA","volume":"138","author":"Amin","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urology.2015.11.042_bib0135","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0022-5347(01)66259-1","article-title":"Prostate specific antigen is metabolized in the liver","volume":"155","author":"Agha","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0090-4295(98)00208-8","article-title":"Determination of the site of metabolism of total, free, and complexed prostate-specific antigen","volume":"52","author":"Kilic","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.11.042_bib0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.urology.2005.01.060","article-title":"Body mass index as a predictor of prostate cancer: development versus detection on biopsy","volume":"66","author":"Freedland","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.11.042_bib0150","article-title":"African American men with Gleason score 3+3=6 prostate cancer produce less PSA than Caucasian men: a potential impact on active surveillance","author":"Kryvenko","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.11.042_bib0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/pcan.2012.39","article-title":"African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center","volume":"16","author":"Tsivian","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T03:23:40Z","timestamp":1567481020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429516000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"alternative-id":["S0090429516000029"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2015.11.042","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate-specific Antigen Mass Density\u2014A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2015.11.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}